Health Condition 1: O351- Maternal care for (suspected) chromosomal abnormality in fetus
Conditions
Interventions
None listed
Sponsors
Dr Cheyne Rosetta Estibeiro
Eligibility
Inclusion criteria
Inclusion criteria: 1)All pregnant women between 9 weeks and 13 weeks 6 days POG presenting for the first trimester visit to OPD 2)Participants who are consenting for enrollment in the study
Exclusion criteria
Exclusion criteria: 1)women with major ultrasonic or chromosomal abnormalities 2)k/c/o insulin dependent diabetes mellitus 3)chronic hypertension 4)cardiac disorder 5)renal disorder 6)multiple gestation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| to assess the association between Beta HCG PLGF and associated PAPP A From 12 weeks period of gestation until 13 weeks 6 days period of gestation with adverse pregnancy outcomes such as preeclampsia, FGR, Pre term delivery, Oligohydramnios, low birth weight, abruptio placenta, Intra uterine death, chromosomal anomalies.Timepoint: From 12 weeks period of gestation until 13 weeks 6 days period of gestation next post delivery in peurperium | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Cheyne Rosetta Estibeiro
Jawaharlal Nehru Medical College, Belagavi.
Outcome results
None listed